About Enovid by Sanotize 

Revolutionizing Protection: The Power of Nitric Oxide in Anti-COVID Nasal Spray
 

A revolutionary nasal spray that protects from viruses. Clinically tested and approved to eliminate 99.9% of the viruses within 2 minutes
 

– Registered Patent –
 

Tests performed with this innovative nasal spray resulted in reducing the concentration of the virus up to 95% within 24 hours and 99% within 72 hours.

On the ongoing battle against the COVID-19 pandemic, innovative solutions are continually emerging to enhance our defenses and protect public health. One such breakthrough is the development of an Anti-COVID Nasal Spray, harnessing the potent properties of nitric oxide to effectively combat viruses.

Nitric oxide (NO) has long been recognized for its antimicrobial properties, and recent research has highlighted its ability to inhibit the replication of various viruses, including coronaviruses. This has paved the way for the creation of a nasal spray that leverages the natural benefits of nitric oxide to offer a groundbreaking level of protection.

Clinical studies have demonstrated the efficacy of the Anti-COVID Nasal Spray, showcasing its ability to neutralize up to 99.9% of viruses, including the SARS-CoV-2 virus responsible for COVID-19. The ease of application, coupled with its rapid action, makes it a convenient and practical tool for individuals looking to enhance their personal protective measures.

Anti-viral nasal spray, registered patent, manufactured in Israel, effective against variety of viruses.

The spray was developed in Canada by SaNOtiza (a biotechnology company) and is manufactured in Israel.

Effective against respiratory viruses, such as the flu.

Can be used up to 5 times per day following contact with viruses.

Suitable for adults and children 12-years old and above.

A 25 ml bottle lasts one-month of daily personal use.

Approved by the MOH (AMR approval).